We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

Sam Boal/

Higher illness benefit for workers absent with Covid-19 ends today

The Enhanced Illness Benefit was introduced during the pandemic for who had to self isolate or restrict their movements due to the virus.

THE HIGHER RATE of illness benefit for people who miss work due to Covid-19 is due to end today.

The Enhanced Illness Benefit (EIB) was a €350-per-week payment for workers who had to self isolate or restrict their movements due to the virus.

Those workers will now have to apply for the standard Illness Benefit, which is paid at a weekly rate of €208.

The EIB was given to employees and self-employed people who were absent from work due to Covid-19 and had a medical certificate from their GP.

It was paid for up to seven days if a person was self-isolating due to being a probable source of infection, and for a maximum of 10 weeks if a person had been diagnosed with Covid-19.

A person currently in receipt of the EIB may have their payments reduced or ceased from tomorrow, depending on their PRSI contributions.

Readers like you are keeping these stories free for everyone...
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.

Your Voice
Readers Comments
This is YOUR comments community. Stay civil, stay constructive, stay on topic. Please familiarise yourself with our comments policy here before taking part.
Leave a Comment
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.

    Leave a commentcancel